|
顯示項目 642381-642405 / 2348674 (共93947頁)
<< < 25691 25692 25693 25694 25695 25696 25697 25698 25699 25700 > >>
每頁顯示[10|25|50]項目
| 國立臺灣大學 |
1999 |
Oral Urografin in Postoperative Small Bowel Obstruction
|
陳石池; 張金堅; 王世名; 陳楷模; 林芳郁; CHEN, SHYR-CHYR; CHANG, KING-JEN; WANG, SHIH-MING; CHEN, KAI-MO; LIN, FANG-YUE |
| 臺大學術典藏 |
2018-09-10T07:20:23Z |
Oral urografin in postoperative small bowel obstruction
|
Chen, S.-C. and Chang, K.-J. and Lee, P.-H. and Wang, S.-M. and Chen, K.-M. and Lin, F.-Y.; PO-HUANG LEE; SHYR-CHYR CHEN |
| 臺大學術典藏 |
2020-03-25T02:37:08Z |
Oral urografin in postoperative small bowel obstruction
|
Lin F.-Y.;Chen K.-M.;Wang S.-M.;Lee P.-H.;Chang K.-J.;SHYR-CHYR CHEN; SHYR-CHYR CHEN; Chang K.-J.; Lee P.-H.; Wang S.-M.; Chen K.-M.; Lin F.-Y. |
| 臺大學術典藏 |
2020-11-19T03:43:14Z |
Oral urografin in postoperative small bowel obstruction
|
Chen S.-C.;Chang K.-J.;Po-Huang Lee;Wang S.-M.;Chen K.-M.;Lin F.-Y.; Chen S.-C.; Chang K.-J.; PO-HUANG LEE; Wang S.-M.; Chen K.-M.; Lin F.-Y. |
| 臺大學術典藏 |
2020-12-16T07:57:11Z |
Oral urografin in postoperative small bowel obstruction
|
Shyr-Chyr Chen;Chang K.-J.;Lee P.-H.;Wang S.-M.;Chen K.-M.;Lin F.-Y.; SHYR-CHYR CHEN; Chang K.-J.; Lee P.-H.; Wang S.-M.; Chen K.-M.; Lin F.-Y. |
| 臺大學術典藏 |
2022-08-12T06:28:55Z |
Oral urografin in postoperative small bowel obstruction
|
Chen S.-C.; KING-JEN CHANG; Lee P.-H.; Wang S.-M.; Chen K.-M.; Lin F.-Y. |
| 臺大學術典藏 |
2019-08-30T03:50:06Z |
Oral vaccination with recombinant Listeria monocytogenes expressing human papillomavirus type 16 E7 can cause tumor growth in mice to regress
|
Lin C.-W.;Lee J.-Y.;Tsao Y.-P.;Shen C.-P.;Lai H.-C.;Show-Li Chen; Lin C.-W.; Lee J.-Y.; Tsao Y.-P.; Shen C.-P.; Lai H.-C.; SHOW-LI CHEN |
| 中國醫藥大學 |
2002-02 |
Oral verruca vulgaris
|
陳玉昆(Chen YK); 薛水上; 林立民(Lin LM); 林正仲(Lin CC); (Terezhalmy GT); (Riley CK); (Moore WS) |
| 國立臺灣大學 |
2007 |
Oral Verruciform Xanthoma: A Clinicopathologic Study of 15 Cases
|
余權航; 蔡東潔; 王拯宗; 劉步遠; 王逸平; 孫安迪; 江俊斌; YU, CHUAN-HANG; TSAI, TUNG-CHIEH; WANG, JENG-TZUNG; LIU, BU-YUAN; WANG, YI-PING; SUN, ANDY; CHIANG, CHUN-PIN |
| 臺大學術典藏 |
2018-09-10T06:15:34Z |
Oral verruciform xanthoma: A clinicopathologic study of 15 cases
|
Yu, C.-H.;Tsai, T.-C.;Wang, J.-T.;Liu, B.-Y.;Wang, Y.-P.;Sun, A.;Chiang, C.-P.; ANDY SUN |
| 臺大學術典藏 |
2021-07-07T02:13:07Z |
Oral verruciform xanthoma: A clinicopathologic study of 15 cases
|
Yu C.-H.; Tsai T.-C.; Wang J.-T.; Liu B.-Y.; YI-PING WANG; Sun A.; Chiang C.-P. |
| 國立成功大學 |
2023 |
Oral verruciform xanthoma: Case report
|
Hwang, M.-J.;Yu-Fong, Chang J.;Chiang, Chiang C.-P.;Jin, Y.-T. |
| 國立臺灣大學 |
2009 |
Oral Verrucous Hyperplasia: Histologic Classification, Prognosis, and Clinical Implications
|
王逸平; 陳信銘; 郭儒銓; 余權航; 孫安迪; 劉步遠; 郭英雄; 江俊斌; WANG, YI-PING; CHEN, HSIN-MING; KUO, RU- CHENG; YU, CHUAN-HANG; SUN, ANDY; LIU, BU-YUAN; KUO, YING-SHIUNG; CHIANG, CHUN-PIN |
| 臺大學術典藏 |
2021-07-07T02:13:04Z |
Oral verrucous hyperplasia: Histologic classification,prognosis, and clinical implications
|
YI-PING WANG; Chen H.-M.; Kuo R.-C.; Yu C.-H.; Sun A.; Liu B.-Y.; Kuo Y.-S.; Chiang C.-P. |
| 臺大學術典藏 |
2021-10-18T06:51:39Z |
Oral verrucous hyperplasia: Histologic classification,prognosis, and clinical implications
|
Wang Y.-P.; HSIN-MING CHEN; Kuo R.-C.; Yu C.-H.; Sun A.; Liu B.-Y.; Kuo Y.-S.; Chiang C.-P. |
| 國立成功大學 |
2008-07 |
Oral-facial-digital syndrome with vaginal atresia, hydronephrosis and congenital cardiac defect
|
Su, Wei-Ren; Wang, Ping-Hui; Lian, Jenn-Dong; Lin, Mark Chii-Jeng |
| 國家衛生研究院 |
2014-04 |
Orally active microtubule-targeting agent, MPT0B271, for the treatment of human non-small cell lung cancer, alone and in combination with erlotinib
|
Tsai, AC;Wang, CY;Liou, JP;Pai, HC;Hsiao, CJ;Chang, JY;Wang, JC;Teng, CM;Pan, SL |
| 臺北醫學大學 |
2014 |
Orally active microtubule-targeting agent, MPT0B271, for the treatment of human non-small cell lung cancer, alone and in combination with erlotinib
|
AC, Tsai;CY, Wang;JP, Liou;HC, Pai;CJ, Hsiao;JY, Chang;JC, Wang;CM, Teng;SL, Pan |
| 臺北醫學大學 |
2014 |
Orally active microtubule-targeting agent, MPT0B271, for the treatment of human non-small cell lung cancer, alone and in combination with erlotinib
|
Tsai, AC;Wang, CY;Liou, JP;Pai, HC;Hsiao, CJ;Chang, JY;Wang, JC;Teng, CM;Pan, SL. |
| 國立成功大學 |
2014-04 |
Orally active microtubule-targeting agent, MPT0B271, for the treatment of human non-small cell lung cancer, alone and in combination with erlotinib
|
Tsai, A-C; Wang, C-Y; Liou, J-P; Pai, H-C; Hsiao, C-J; Chang, J-Y; Wang, J-C; Teng, C-M; Pan, S-L |
| 國立臺灣大學 |
2014 |
Orally active microtubule-targeting agent, MPT0B271, for the treatment of human non-small cell lung cancer, alone and in combination with erlotinib
|
Tsai, A-C; Wang, C-Y; Liou, J-P; Pai, H-C; Hsiao, C-J; Chang, J-Y; Wang, J-C; Teng, C-M; Pan, S-L; 鄧哲明 |
| 臺北醫學大學 |
1997 |
Orally administered iodinated recombinant human insulin-like growth factor-I (125I-rhIGF-I) is poorly absorbed by the newborn piglet.
|
趙振瑞; Donovan SM; Chao JC-J; Zijlstra RT; and Odle J |
| 實踐大學 |
2011 |
Orally administered mycelial culture of Phellinus linteus exhibits antitumor effects in hepatoma cell-bearing mice
|
Huang, H.Y.;Chieh, S.Y.;Tso, T.K.;Chien, T.Y.;Lin, H.T.;Tsai, Y.C. |
| 亞洲大學 |
2019-08 |
Orally administered resveratrol enhances the therapeutic effect of autologous transplanted adipose-derived stem cells on rats with diabetic hepatopathy
|
Chen, T.-S.;Chen, T.-S.;Lai, C.-H.;Lai, C.-H.;Shen, C.-Y.;Shen, C.-Y.;Pai, P.-Y.;Pai, P.-Y.;Chen, R.-J.;Chen, R.-J.;PadmaVisw, V.;PadmaViswanadha, V.;Yang, C.-K.;Yang, C.-K.;Chen, M.-C.;Chen, M.-C.;Lin, Y.-M.;Lin, Y.-M.;黃志揚;Huang, Chih-Yang |
| 國家衛生研究院 |
2025-02-27 |
Orally bioavailable and site-selective covalent STING inhibitor derived from a macrocyclic marine diterpenoid
|
Niu, GH;Hsiao, WC;Lee, PH;Zheng, LG;Yang, YS;Huang, WC;Hsieh, CC;Chiu, TY;Wang, JY;Chen, CP;Huang, CL;You, MS;Kuo, YP;Wang, CM;Wen, ZH;Yu, GY;Chen, CT;Chi, YH;Tung, CW;Hsu, SC;Yeh, TK;Sung, PJ;Zhang, MZM;Tsou, LK |
顯示項目 642381-642405 / 2348674 (共93947頁)
<< < 25691 25692 25693 25694 25695 25696 25697 25698 25699 25700 > >>
每頁顯示[10|25|50]項目
|
